Corrective Actions "Inadequate," FDA Warns Ranbaxy

 
• By The Pink Sheet Daily

U.S. regulators threaten seizure and injunction at Ohm Labs' Gloversville, N.Y., facility.

More from Archive

More from Pink Sheet